Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.67 |
| ▸ | CA2 | P00918 | 2/20 | 0.67 |
| ▸ | CA7 | P43166 | 2/20 | 0.67 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | NPC1 | O15118 | 4/20 | 0.64 |
| ▸ | RAB9A | P51151 | 6/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiophene SCHEMBL8338314 | 0.89 | CA1 (0.56) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL9787043 | 0.88 | CA1 (0.64) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL9787355 | 0.88 | ALDH1A1 (0.59) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL28981219 | 0.88 | RAB9A (0.59) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL1447641 | 0.88 | CA1 (0.59) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL10874649 | 0.87 | NPC1 (0.65) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL3956515 | 0.87 | CA1 (0.58) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL9787308 | 0.87 | CA1 (0.62) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL9787096 | 0.87 | ALDH1A1 (0.59) | CA1CA2CA7CA13FFAR1 | |
| SCHEMBL11811575 | 0.87 | RAB9A (0.65) | CA1CA2CA7CA13FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114605157-B | Photocuring aluminum nitride ceramic slurry and preparation method thereof | 广东工业大学 | 2023-04-18 | — | — | CN | claimed |
| CN-114605157-A | Photocuring aluminum nitride ceramic slurry and preparation method thereof | 广东工业大学 | 2022-06-10 | — | — | CN | claimed |
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | claimed |
| US-20110130482-A1 | Process for preparing armatic thiophenyl ketones | PRETOR ROGER | 2011-06-02 | — | — | US | claimed |
| EP-1799638-B1 | PROCESS FOR PREPARING AROMATIC THIOPHENYL KETONES | CIBA HOLDING INC (CH) | 2008-07-30 | — | — | EP | claimed |
| CN-101031543-A | Process for preparing aromatic thiophenyl ketones | CIBA SC HOLDING AG (CH) | 2007-09-05 | — | — | CN | claimed |
| EP-1799638-A1 | PROCESS FOR PREPARING AROMATIC THIOPHENYL KETONES | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2007-06-27 | — | — | EP | claimed |
| WO-2006034966-A1 | PROCESS FOR PREPARING AROMATIC THIOPHENYL KETONES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-04-06 | — | — | WO | claimed |
| EP-1599743-A2 | THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE | Heuris Pharma LLC (US) | 2005-11-30 | — | — | EP | claimed |
| US-20040211917-A1 | Three-dimensional dosimeter for penetrating radiation and method of use | HEURIS PHARMA, LLC | 2004-10-28 | — | — | US | claimed |
| WO-2004079393-A2 | THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE | HEURIS PHARMA LLC (US) | 2004-09-16 | — | — | WO | claimed |
| EP-4553061-A1 | METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-05-14 | — | — | EP | disclosed |
| CN-119403778-A | Process for producing fluorinated organic compound | 大金工业株式会社 | 2025-02-07 | — | — | CN | disclosed |
| US-20240196725-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-06-13 | — | — | US | disclosed |
| CN-117917420-A | Organometallic compound, light-emitting device, electronic apparatus, and electronic device | 三星显示有限公司 | 2024-04-23 | — | — | CN | disclosed |
| US-4133814-A | ANTITUMOR AGENTS | ELI LILLY AND COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4107012-A | COATINGS, PRINTING INKS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-15 | — | — | US | disclosed |
| US-4075227-A | NONSTEROIDAL | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4054682-A | COATINGS, PRINTING INKS | BASF AKTIENGESELLSCHAFT (DT) | 1977-10-18 | — | — | US | disclosed |
| US-3997627-A | Polyester molding compositions containing hydroxy containing vinyl monomers and coated molded articles thereof | MITSUBISHI RAYON CO., LTD. (JA) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110130482-A1 | Process for preparing armatic thiophenyl ketones | ACOT7, AGPAT2, COASY | CA1 3488/4885CA2 3969/4885CA7 1316/4885 |
| US-20240196725-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE | L1CAM, LEF1, LAGE3 | CA1 3595/4885CA2 4559/4885CA7 4210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.